|
KMID : 0369820080380030191
|
|
Jorunal of Korean Pharmaceutical Sciences
2008 Volume.38 No. 3 p.191 ~ p.197
|
|
|
Pharmacokinetics and Lymphatic Delivery of Oligopeptide after Intramuscular Injection of Oligopeptide-bearing Liposomes to Rats
|
|
Shin Dae-Hwan
Cho Byung-Suk
Choi Kyu-Seok
Song Suk-Gil
Lee Chong-Kil
Jung Yeun-Bok
|
|
|
Abstract
|
|
|
|
The purpose of the present study was to examine the pharmacokinetics and lymphatic delivery of the oligopeptide, a model peptide of X antigen epitope peptides, after the intramuscular administration of the peptide-bearing liposomes in rats. -labelled peptide was used as a tracer to analyze the peptide levels in plasma, bile, urine, tissue homogenates, and lymph nodes (superior cervical nodes, brachial nodes and superior mesenteric nodes). Model peptide rapidly disappeared from the plasma by 30 min ( phase) after i.v. administration, which was followed by the late disappearance. The apparent plasma half-lives () of the peptide at the phase when administered at a dose of 0.2-1.0 mg/kg were about 5 min. The maximum plasma concentration () was , after the i.m. administration of the peptide at a dose of 1.0 mg/kg. The bioavailability, which was calculated from the time zero to last quantitative time, of the i.m. administered peptide was over 60%. Of the various tissues tested, the peptide was mainly distributed in the kidney after the i.m. administration. The peptide levels in the kidney 3 hr after the i.m. administration were higher than those of maximum plasma concentration (). The cumulative amounts of the peptide found in the urine 72 hr after the administration of 1.0 mg/kg were 2-folder higher than those in the bile, suggesting that the peptide is mostly excreted in the urine. Moreover, the concentrations of the peptide in the lymph nodes were as high as that of the plasma and the tissues. In conclusion, the peptide concentration in the lymph nodes was maintained by 24 hr after the i.m. administration of the peptide-bearing liposomes.
|
|
|
KEYWORD
|
|
|
Oligopeptide, Pharmacokinetics, Lymphatic delivery, Liposomes
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|